Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.

Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Abstract Text:

    claudia steurer-steyClaudia Steurer-Stey,leonie laglerLeonie Lagler,daniel a straubDaniel A Straub,johann steurerJohann Steurer,lucas m bachmannLucas M Bachmann,

    BACKGROUND: Recurrent acute respiratory tract infections (ARTI) are a common problem in childhood. Some evidence suggests a benefit regarding the prevention of ARTI in children treated with the immunomodulator OM-85 BV (Bronchovaxom). METHODS: We summarised the evidence on the effectiveness of the immunomodulator OM-85 BV in the prevention of ARTI in children. We searched randomised comparisons of oral purified bacterial extracts against inactive controls in children with respiratory tract diseases in nine electronic databases and reference lists of included studies. We extracted salient features of each study, calculated relative risks (RR) or weighted mean differences (WMD) and performed meta-analyses using random-effects models. RESULTS: Thirteen studies (2,721 patients) of low to moderate quality tested OM-85 BV. Patients and outcomes differed substantially, which impeded pooling results of more than two trials. Two studies (240 patients) reporting on the number of patients with less than three infections over 6 month of follow-up in children not in day care showed a trend for benefit RR 0.82 (95% CI, 0.65-1.02). One out of two studies examining the number of children not in day care without infections over 4-6 month reported a significant RR of 0.42 (95% CI, 0.21-0.82) whereas the smaller, second study did not [RR 0.92 (95% CI, 0.58-1.46)]. Two studies reporting the number of antibiotic courses indicated a benefit for the intervention arm [WMD 2.0 (95% CI, 1.7-2.3)]. Two out of the three studies showed a reduction of length of episodes of 4-6 days whereas a third study showed no difference between the two groups. CONCLUSION: Evidence in favour of OM-85 BV in the prevention of ARTI in children is weak. There is a trend for fewer and shorter infections and a reduction of antibiotic use.

    Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Publishing Authors By Initials

    c steurer-steyC Steurer-Stey,l laglerL Lagler,da straubDA Straub,j steurerJ Steurer,lm bachmannLM Bachmann,

    For similar bacterial infections and mycoses: infection: respiratory tract infections research abstracts see: bacterial infections and mycoses: infection: respiratory tract infections research

    PUBMED ID PMID:

    MEDLINE DATE:

    Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Journal Published:

    PUBLICATION TYPE: Review

    Journal: European journal of pediatrics

    VOLUME: 166

    Page Numbers: 365-76

    Journal Abbreviation: Eur. J. Pediatr.

    ISSN: 0340-6199

    DAY: 18

    MONTH: 11

    YEAR: 2006

    Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Information

    Number of References: 23

    LANGUAGE: eng

    NlmUniqueID: 7603873

    Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Keywords Mesh Terms:

    KEYWORDS: Respiratory Tract Infections

    MESH TERMS: prevention & control

    Chemical & Substance for Abstract: Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Information

    Substance Name: bacterial lysate

    Registry Number: 0

    Grant and Affiliation Information for Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.

    AFFILIATION: Medical Policlinic, Department of Internal Medicine, University Hospital, Raemistrasse 100, CH-8091, Zurich, Switzerland. claudia.stey@usz.ch

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur J Pediatr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News